{"id":1203,"date":"2018-10-26T10:49:23","date_gmt":"2018-10-26T08:49:23","guid":{"rendered":"https:\/\/www.future-live.com\/titolo-news-oggi\/"},"modified":"2019-01-10T10:48:29","modified_gmt":"2019-01-10T09:48:29","slug":"the-new-adjuvant-for-candida-albicans-is-launched-on-october-26-2018","status":"publish","type":"post","link":"https:\/\/www.future-live.com\/en\/the-new-adjuvant-for-candida-albicans-is-launched-on-october-26-2018\/","title":{"rendered":"The new adjuvant for Candida albicans is launched on October 26, 2018"},"content":{"rendered":"

Last October 4th at the Hotel Principe di Lazise, there was a presentation to the entire Future Live Medical Information network of Decand<\/strong>, of an innovative nutraceutical based on Saccharomyces Cerevisiae CNCM I 3856, with specific adjuvant activity of antifungal therapy during candida vaginitis.<\/p>\n

Decand<\/strong> contains Saccharomyces Cerevisiae CNCM I 3856, a particular yeast strain, selected and studied in France from over 6,000 species and deposited at the Pasteur Institute in Paris, This innovative yeast has been studied at microbiological and clinical level and has demonstrated the ability to protect the flora vaginal from the aggressions of potentially pathogenic yeasts such as Candida albicans.<\/p>\n

Among the various speakers was Dr. Eva Pericolini, a microbiologist at the University of Modena, who illustrated the peculiar characteristics of this yeast in light of the studies carried out at her institution.<\/p>\n

Future Live is currently involved in presenting Decand to medical specialists throughout the country.<\/p>\n","protected":false},"excerpt":{"rendered":"Last October 4th at the Hotel Principe di Lazise, there was a presentation to the entire Future Live Medical Information network of Decand, of an innovative nutraceutical based on Saccharomyces Cerevisiae CNCM I 3856, with specific adjuvant activity of antifungal therapy during candida vaginitis. Decand contains Saccharomyces Cerevisiae CNCM I 3856, a particular yeast strain, selected and studied in France from over 6,000 species and deposited at the Pasteur Institute in Paris, This innovative yeast has been studied at microbiological and clinical level and has demonstrated the ability to protect the flora vaginal from the aggressions of potentially pathogenic yeasts such as Candida albicans. Among the various speakers was Dr. Eva Pericolini, a microbiologist at the University of Modena, who illustrated the peculiar characteristics of this yeast in light of the studies carried out at her institution. Future Live is currently involved in presenting Decand to medical specialists throughout the country.","protected":false},"author":1,"featured_media":1150,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"yoast_head":"\nThe new adjuvant for Candida albicans is launched on October 26, 2018 - Future Live Srl<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.future-live.com\/titolo-news-oggi\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The new adjuvant for Candida albicans is launched on October 26, 2018 - Future Live Srl\" \/>\n<meta property=\"og:description\" content=\"Last October 4th at the Hotel Principe di Lazise, there was a presentation to the entire Future Live Medical Information network of Decand, of an innovative nutraceutical based on Saccharomyces Cerevisiae CNCM I 3856, with specific adjuvant activity of antifungal therapy during candida vaginitis. Decand contains Saccharomyces Cerevisiae CNCM I 3856, a particular yeast strain, selected and studied in France from over 6,000 species and deposited at the Pasteur Institute in Paris, This innovative yeast has been studied at microbiological and clinical level and has demonstrated the ability to protect the flora vaginal from the aggressions of potentially pathogenic yeasts such as Candida albicans. Among the various speakers was Dr. Eva Pericolini, a microbiologist at the University of Modena, who illustrated the peculiar characteristics of this yeast in light of the studies carried out at her institution. Future Live is currently involved in presenting Decand to medical specialists throughout the country.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.future-live.com\/titolo-news-oggi\/\" \/>\n<meta property=\"og:site_name\" content=\"Future Live Srl\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/FutureLivesrl\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-10-26T08:49:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-01-10T09:48:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/10\/foto_DECAND_420x270.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"420\" \/>\n\t<meta property=\"og:image:height\" content=\"270\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mollusco.MEB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"mollusco.MEB\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.future-live.com\/titolo-news-oggi\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.future-live.com\/titolo-news-oggi\/\"},\"author\":{\"name\":\"mollusco.MEB\",\"@id\":\"https:\/\/www.future-live.com\/#\/schema\/person\/baf94d4b22f8a3841c77fd8ed230616c\"},\"headline\":\"The new adjuvant for Candida albicans is launched on October 26, 2018\",\"datePublished\":\"2018-10-26T08:49:23+00:00\",\"dateModified\":\"2019-01-10T09:48:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.future-live.com\/titolo-news-oggi\/\"},\"wordCount\":158,\"publisher\":{\"@id\":\"https:\/\/www.future-live.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.future-live.com\/titolo-news-oggi\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/10\/foto_DECAND_420x270.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.future-live.com\/titolo-news-oggi\/\",\"url\":\"https:\/\/www.future-live.com\/titolo-news-oggi\/\",\"name\":\"The new adjuvant for Candida albicans is launched on October 26, 2018 - Future Live Srl\",\"isPartOf\":{\"@id\":\"https:\/\/www.future-live.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.future-live.com\/titolo-news-oggi\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.future-live.com\/titolo-news-oggi\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/10\/foto_DECAND_420x270.jpg\",\"datePublished\":\"2018-10-26T08:49:23+00:00\",\"dateModified\":\"2019-01-10T09:48:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.future-live.com\/titolo-news-oggi\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.future-live.com\/titolo-news-oggi\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.future-live.com\/titolo-news-oggi\/#primaryimage\",\"url\":\"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/10\/foto_DECAND_420x270.jpg\",\"contentUrl\":\"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/10\/foto_DECAND_420x270.jpg\",\"width\":420,\"height\":270},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.future-live.com\/titolo-news-oggi\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.future-live.com\/en\/home-page\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The new adjuvant for Candida albicans is launched on October 26, 2018\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.future-live.com\/#website\",\"url\":\"https:\/\/www.future-live.com\/\",\"name\":\"Future Live Srl\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.future-live.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.future-live.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.future-live.com\/#organization\",\"name\":\"Future Live\",\"url\":\"https:\/\/www.future-live.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.future-live.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/05\/logo-con-sfondo-bianco.png\",\"contentUrl\":\"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/05\/logo-con-sfondo-bianco.png\",\"width\":1428,\"height\":1315,\"caption\":\"Future Live\"},\"image\":{\"@id\":\"https:\/\/www.future-live.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/FutureLivesrl\/\",\"https:\/\/www.linkedin.com\/company\/future-live-srl\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.future-live.com\/#\/schema\/person\/baf94d4b22f8a3841c77fd8ed230616c\",\"name\":\"mollusco.MEB\",\"url\":\"https:\/\/www.future-live.com\/en\/author\/mollusco-meb\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The new adjuvant for Candida albicans is launched on October 26, 2018 - Future Live Srl","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.future-live.com\/titolo-news-oggi\/","og_locale":"en_US","og_type":"article","og_title":"The new adjuvant for Candida albicans is launched on October 26, 2018 - Future Live Srl","og_description":"Last October 4th at the Hotel Principe di Lazise, there was a presentation to the entire Future Live Medical Information network of Decand, of an innovative nutraceutical based on Saccharomyces Cerevisiae CNCM I 3856, with specific adjuvant activity of antifungal therapy during candida vaginitis. Decand contains Saccharomyces Cerevisiae CNCM I 3856, a particular yeast strain, selected and studied in France from over 6,000 species and deposited at the Pasteur Institute in Paris, This innovative yeast has been studied at microbiological and clinical level and has demonstrated the ability to protect the flora vaginal from the aggressions of potentially pathogenic yeasts such as Candida albicans. Among the various speakers was Dr. Eva Pericolini, a microbiologist at the University of Modena, who illustrated the peculiar characteristics of this yeast in light of the studies carried out at her institution. Future Live is currently involved in presenting Decand to medical specialists throughout the country.","og_url":"https:\/\/www.future-live.com\/titolo-news-oggi\/","og_site_name":"Future Live Srl","article_publisher":"https:\/\/www.facebook.com\/FutureLivesrl\/","article_published_time":"2018-10-26T08:49:23+00:00","article_modified_time":"2019-01-10T09:48:29+00:00","og_image":[{"width":420,"height":270,"url":"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/10\/foto_DECAND_420x270.jpg","type":"image\/jpeg"}],"author":"mollusco.MEB","twitter_card":"summary_large_image","twitter_misc":{"Written by":"mollusco.MEB","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.future-live.com\/titolo-news-oggi\/#article","isPartOf":{"@id":"https:\/\/www.future-live.com\/titolo-news-oggi\/"},"author":{"name":"mollusco.MEB","@id":"https:\/\/www.future-live.com\/#\/schema\/person\/baf94d4b22f8a3841c77fd8ed230616c"},"headline":"The new adjuvant for Candida albicans is launched on October 26, 2018","datePublished":"2018-10-26T08:49:23+00:00","dateModified":"2019-01-10T09:48:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.future-live.com\/titolo-news-oggi\/"},"wordCount":158,"publisher":{"@id":"https:\/\/www.future-live.com\/#organization"},"image":{"@id":"https:\/\/www.future-live.com\/titolo-news-oggi\/#primaryimage"},"thumbnailUrl":"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/10\/foto_DECAND_420x270.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.future-live.com\/titolo-news-oggi\/","url":"https:\/\/www.future-live.com\/titolo-news-oggi\/","name":"The new adjuvant for Candida albicans is launched on October 26, 2018 - Future Live Srl","isPartOf":{"@id":"https:\/\/www.future-live.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.future-live.com\/titolo-news-oggi\/#primaryimage"},"image":{"@id":"https:\/\/www.future-live.com\/titolo-news-oggi\/#primaryimage"},"thumbnailUrl":"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/10\/foto_DECAND_420x270.jpg","datePublished":"2018-10-26T08:49:23+00:00","dateModified":"2019-01-10T09:48:29+00:00","breadcrumb":{"@id":"https:\/\/www.future-live.com\/titolo-news-oggi\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.future-live.com\/titolo-news-oggi\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.future-live.com\/titolo-news-oggi\/#primaryimage","url":"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/10\/foto_DECAND_420x270.jpg","contentUrl":"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/10\/foto_DECAND_420x270.jpg","width":420,"height":270},{"@type":"BreadcrumbList","@id":"https:\/\/www.future-live.com\/titolo-news-oggi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.future-live.com\/en\/home-page\/"},{"@type":"ListItem","position":2,"name":"The new adjuvant for Candida albicans is launched on October 26, 2018"}]},{"@type":"WebSite","@id":"https:\/\/www.future-live.com\/#website","url":"https:\/\/www.future-live.com\/","name":"Future Live Srl","description":"","publisher":{"@id":"https:\/\/www.future-live.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.future-live.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.future-live.com\/#organization","name":"Future Live","url":"https:\/\/www.future-live.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.future-live.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/05\/logo-con-sfondo-bianco.png","contentUrl":"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/05\/logo-con-sfondo-bianco.png","width":1428,"height":1315,"caption":"Future Live"},"image":{"@id":"https:\/\/www.future-live.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/FutureLivesrl\/","https:\/\/www.linkedin.com\/company\/future-live-srl\/"]},{"@type":"Person","@id":"https:\/\/www.future-live.com\/#\/schema\/person\/baf94d4b22f8a3841c77fd8ed230616c","name":"mollusco.MEB","url":"https:\/\/www.future-live.com\/en\/author\/mollusco-meb\/"}]}},"views":1101,"_links":{"self":[{"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/posts\/1203"}],"collection":[{"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/comments?post=1203"}],"version-history":[{"count":0,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/posts\/1203\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/media\/1150"}],"wp:attachment":[{"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/media?parent=1203"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/categories?post=1203"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/tags?post=1203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}